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Hispanic CF patients: lower vs higher soc ioeconomic  status 
E. Hs~a, L.K. Fukushima, M.S. Woo 
Div. of Ped PuImonology, ChiMren's Hospital Los Angeles, USC Keck School of 
Medicine. Los Angeles, CA, U.S.A. 
Hispanic CF pts l iving in the United States (US) have increased morbidityhnor t ality 
compared to non Hispanic Caucasians. Is this difference due to socioeconomic 
factors? We compared Hispanic CF quality of l ife (QoL), weight, height, BMI, mad 
FEV 1 ha lower vs higher socioeconomic status (SES). Lower SES was defined as pts 
with single mothers and family income <$25,CO)/yr. Inclusion criteria: age >6 yrs; 
Hispanic etlmicity; perform PFTs; documented CF (by sweat chloride and/or 
CFDNA) and completed CFQ. Data was analyzed using Student's t test mad 
Fisher's exact. The validated CF quality of l ife (CFQ) were scored by computerized 
software (score 0 1CO;1CO~elter QoL). 2CO pediatric pts are followed at our CF 
Center. 50% of our CF pts are classified as Hispanic. 32 pts met inclusion criteria. 
10 (mean age 11.7+4.2 yrs; 5 M:5 F) were classified as lower SES and 22 (mean 
age 13.1+3.4 yrs, p 0.37; 15 M:8 F, p 0.46) were higher SES. There was no 
difference ha height (p~).27), weight (p 0.39), BMI  (p~).91), and FEV 1 (p~).50). 
In comparing CFQ domains, lower SES pts had lower scores in the Physical domain 
(p~).CO6) compared to the higher SES patients. There were no significant 
differences ha CFQ domains of Emotion (p~).37), Social (p 0.19), Body Image 
(p~).09), Eating (p 0.57), Treatment Burden (p~).66), Respiratory (p~).08), mad 
Digestion (p 0.87). We conclude that lower SES Hispanic CF pts report lower 
physical functioning compared to the higher SES group in the same Center. 
However, lower physical functioning was not related to differences in PFTs, 
nutrition, Eating, Respiratory, or Socialization. We speculate that factors other than 
SES status contribute to increased morbidity mad mortality in Hispanic CF pts l iving 
in the US. 
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Motivational Interviewing As A Bridge To Shared Decision Making: 
Preliminary Results Of A Team-Cenked Programme 
G. Ullr ich 1, G. Kremer 2, G. Steinkamp / 
~Hannover Medical School, Dep. Paediauics; 2psychiatric Clinics Gilead, Dep. 
Addictive disorders, Bielefeld- Bethel; SCF-cenue Hamburg-Ahona; all Germany 
AIMS : to improve management of adherence related problems. 
METHODS:  stall" education, on request performed as an in house programme for 
CF teams; 3 hal f  day courses covering: (1.) basic concepts (e.g. health beliefs, 
shared ecision making), findings from general compliance research mad respective 
CF research, organisational issues (e.g. improve teamwork); (2. + 3.): introduction 
into the concept of "motivational interviewing"* (role of ambivalence ha decision 
making, stages of a change, reflective listening, deal ing with resistance). 
Al l  (n 120) German CF centres were informed about the programme and the fee 
(450 ~ per team). Enrol lment was possible as (a) an ha house course for the whole 
cf team; (b) incomplete team together with another incomplete team; (c) single 
member to participate ha a regional, not in house course. 
RESULTS: 34 centres registered, of whom 18 chose to participate as a "whole 
team". Up to now 3 courses were completed (47 participants from 4 centres). The 
evaluation of the programme is focussed on participant satisfaction (e.g. perceived 
relevance of the issues) and on qualitative data (personal main benefits). 
Prel iminary results show that participants prefer information and practice re 
communication skills and motivational interviewing (days 2 + 3) over basic 
concepts (day 1). 
CONCLUSIONS: Today, German CF centres are plagued with reimbursement 
iss~aes. Therefore, we  speculated whether an ambitious course like ours, would still 
meet their needs. The large number of enrolled CF teams is very encouraging, 
though. 
*Rollnick et al. (1999) Health behavior change. Churchil l  Livingstone: Eingburgh 
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The relationship between adherence to medication, non-attendance at 
clinic and disease severity in children with cystic fibrosis 
A. Scomey 1, C. Silburn ~, K. Brownlee ~
~Booth Hail ChiMren's Hospital, Manchester; UK, 2RegionaI Paediau ic CF Unit, St 
James' University Hospital, Leeds, UK 
I n lmduet lon  Poor adherence to treatment and clinic attendance is recognised ha 
cbronic disease. Optimal adherence is associated with improved outcome. This 
study investigates relationships between adherence, attendance mad outcome ha 
children with CF. 
Method Expected medication issues were derived from medical notes. Adherence 
was estimated from hospital pharmacy issues and GP repeat prescription data for 
prophylactic antibiotics and pancreatic enzymes for 2 yrs. An  adherence score was 
calculated. Clinic non attendance was similarly scored. Clinical outcome data were 
collected for 6 months at the end of the study period. Primary outcome measure was 
best % FEVI, with secondary measures including BMI  SDS. 
Results Data were collected on 59 patients (39 of 508 homozygote). The 
homozygous group alone was used for analysis of cl inical outcome. 
Median adherence rate was 73% (IQR: 53 94%), antibiotic adherence was 82% 
(50 1CO%), and enzyme adherence was 76% (50 100%). 
There were dose response trends between adherence and %FEV1 (p~3.18) mad 
%FEFg~ 75 (p~3.025), but no relationship with BMI.  
Adherence was ignificantly correlated with Staphylococcus aureus isolation 
(p~3.026). There was a weak  but non significant correlation with Pseudomonas 
aeruginosa status (p 0.27), DNA rate (p~). 12) and cancellation rate (p 0.42). 
Conclusion We have assessed one component of adherence: collecting medication. 
This is the maximum amount of treatment a patient could have taken. Actual 
adherence could have been much less. This study shows there is a relationship 
between this measure of adherence, non attendance mad disease outcome. 
Adherence needs to be addressed if we are to improve outcomes. 
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Talking about death: But what about the transplant patient? 
H.J. Bar tig, R. Wfinderich, G. Ul lr ich 
Hannover Medical School, Dep. Paediatrics 
CF was formerly known as a "kil ler disease". Although still uncur able, the way of 
thinking about CF and of speaking to those afflicted has dramatically shit~ed 
towards a positive outlook.* The option of transplantation is one of several reasons 
for this new paradigm. And, certainly, l isting for transplant not only is a credible 
reason for hope in the most desperate disease states. It is also a very powerful 
symbol for all involved: that premature death may eventually be banned. However, 
when it comes to dying, this optimistic potential may wel l  tum into a curse: from 
our cl inical impression it is the rare exception rather than the rule that the terminal ly 
il l  patient and his relatives are able to maintain hope and to prepare for death at the 
same time! Instead, the optimistic outlook of rescue is a most tempting reason for 
all involved to deny death as the most probable forthcoming event. 
During the pre transplant era, for health professionals talking about death seemed 
so difficult because of the "do not harm" obligation (don't destroy hope). It took a 
very long t ime to discover that not talking about impending death was harmful, too. 
Denial  of death rather became an issue of malpractice, then. I f  patients are listed for 
transplant, maintaining hope is an essential prerequisite for endurance. Therefore, it 
may be quite r asonable for health professionals not to talk about death, today !Yet, 
we  now know that not talking about death is malpractice, too! Furthermore, l isting 
for transplant may even serve as a surrogate for talking about death mad for getting 
a mounaing prccess started. Since death on the wait ing list wi l l  remain far from 
being exceptional, there is an urgent need to solve this new di lemma. 
*Markovitz (2CO1) ha: Bluebond Langner et al.(eds) PsychosociaI spects of cystic 
fibrosis (pp. 380 9). London: Arnold 
